MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance

BACKGROUND: Development of resistance to androgen deprivation therapy (ADT) is a major obstacle for the management of advanced prostate cancer. Therapies with androgen receptor (AR) antagonists and androgen withdrawal initially regress tumors but development of compensatory mechanisms including AR b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottman, Richard, Nguyen, Camha, Lorch, Robert, Chakrabarti, Ratna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896800/
https://www.ncbi.nlm.nih.gov/pubmed/24387052
http://dx.doi.org/10.1186/1476-4598-13-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896800/
https://www.ncbi.nlm.nih.gov/pubmed/24387052
http://dx.doi.org/10.1186/1476-4598-13-1

Ejemplares similares